glucose, (beta-d)-isomer has been researched along with Nephrolithiasis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balasubramanian, P; Elsaesser, A; Ferreira, JP; Inzucchi, SE; Ofstad, AP; Wanner, C; Zinman, B | 1 |
1 trial(s) available for glucose, (beta-d)-isomer and Nephrolithiasis
| Article | Year |
|---|---|
Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition?
Topics: Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucosides; Humans; Hypoglycemic Agents; Nephrolithiasis; Prospective Studies; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; Urinary Calculi | 2022 |